Skip to content

The relationship between vitiligo and thyroid antibody and its function

The relationship between vitiligo and thyroid antibody and its function

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033682
Enrollment
Unknown
Registered
2020-06-09
Start date
2020-06-01
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo

Interventions

Vitiligo group:no intervention
Healthy control group:no intervention

Sponsors

Department of Dermatology, the First Affiliated Hospital of Harbin Medical University, Harbin, China
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Vitiligo was diagnosed by three doctors according to typical clinical manifestations and auxiliary examinations.Vitiligo is a depigmentation disease that can occur in any part of the body. The majority of skin lesions present as clear white spots or plaques, and the surrounding skin is unaffected. Vitiligo can be divided into two types: segmental and non-segmental. The former is characterized by skin lesions distributed along the ganglia segment, which are mostly unilateral and asymmetrical. The diagnosis can also be assisted by the use of Wood's lamp (bright white fluorescence).

Exclusion criteria

Exclusion criteria: Incomplete medical records, pregnant women, diabetes, tuberculosis, tumors, severe heart, liver, and kidney dysfunction, use of immunosuppressants and glucocorticoids within the past six months.

Design outcomes

Primary

MeasureTime frame
Thyroid function and antibody;

Countries

China

Contacts

Public ContactFeng Zhang

Department of Dermatology, the First Affiliated Hospital of Harbin Medical University

z11f99@163.com+86 0451-85553842

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026